Boston, MA, United States of America

Deborah K Dila

This inventor holds 1 USPTO granted patent. Top assignee: New England Biolabs, Inc.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deborah K Dila. Retrieved from https://idiyas.com/inventor/deborah-k-dila

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Deborah K. Dila: Inventor in Biotechnology.

Introduction

Deborah K. Dila is an inventor associated with New England Biolabs, Inc., in Boston, Massachusetts. Her work includes a patented method for cloning nuclease genes directly in *E. coli*.

Latest Patents

Dila is credited with 1 patent: “Method for Direct Cloning of Nuclease Genes in *E. coli*.” The invention describes a method for directly cloning nuclease genes, including restriction endonuclease genes, in *E. coli*. It also provides a strain designed to facilitate the method, which was used to clone multiple genes encoding endonucleases.

Career Highlights

Dila’s patent reflects work in molecular biology and genetic engineering, particularly methods for cloning genes that encode nucleases. The supplied information associates her with New England Biolabs, Inc.

Collaborations

Aleksei Fomenkov and Shuang-Yong Xu are identified as Dila’s coworkers. Their shared association points to a collaborative research environment focused on biotechnology and molecular biology.

Conclusion

Deborah K. Dila’s documented invention contributes a direct-cloning approach for nuclease genes in *E. coli*, supported by a specialized strain and developed in connection with her work at New England Biolabs, Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…